title: [Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].
authors.affiliation: Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Yamamura
authors.forename: Osamu
authors.initials: O
authors.lastname: Sato
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Fujiki
mesh_terms: D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000494:pharmacology / Q000627:therapeutic use*; D001826:Body Fluids / Q000378:metabolism; D002986:Clinical Trials as Topic; D004231:Diuresis / Q000187:drug effects; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007010:Hyponatremia / Q000150:complications / Q000188:drug therapy; D000077602:Tolvaptan
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D000077602:Tolvaptan